More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$129484532
EPS
0.13
P/E ratio
--
Price to sales
2.39
Dividend yield
--
Beta
1.304793
Previous close
$8.98
Today's open
$9
Day's range
$8.35 - $9
52 week range
$7.50 - $13.47
show more
CEO
Sanjiv Razdan
Employees
794
Headquarters
Scottsdale, AZ
Exchange
NASDAQ Capital Market
Shares outstanding
14866192
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
Southeast Buyers are Existing Members of the Franchise Community, Further Increasing their Ownership Southeast Buyers are Existing Members of the Franchise Community, Further Increasing their Ownership
GlobeNewsWire • Dec 11, 2025

Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals"
SCOTTSDALE, Ariz. , Nov. 17, 2025 /PRNewswire/ -- The holidays can feel like a full-contact sport for your back.
PRNewsWire • Nov 17, 2025

The Joint Corp. (JYNT) Q3 2025 Earnings Call Transcript
The Joint Corp. ( JYNT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Sanjiv Razdan - CEO, President & Director Scott Bowman - Chief Financial Officer Conference Call Participants Jeff Van Sinderen - B. Riley Securities, Inc., Research Division George Kelly - ROTH Capital Partners, LLC, Research Division Thomas McGovern Presentation Operator Good day, and welcome to the Joint Corporation Third Quarter 2025 Financial Results Conference Call.
Seeking Alpha • Nov 7, 2025

The Joint Corp. (JYNT) Beats Q3 Earnings and Revenue Estimates
The Joint Corp. (JYNT) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.04 per share a year ago.
Zacks Investment Research • Nov 7, 2025

The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List
SCOTTSDALE, Ariz. , Oct. 7, 2025 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has been recognized on the annual Franchise Times Top 400.
PRNewsWire • Oct 7, 2025

The Joint Chiropractic Debuts in Delaware
-First Location Now Open in Dover- SCOTTSDALE, Ariz. , Oct. 3, 2025 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has opened its first clinic in the state of Delaware.
PRNewsWire • Oct 3, 2025

The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer
- CMO with extensive experience in brand building, franchising and strategic growth – - CMO with extensive experience in brand building, franchising and strategic growth –
GlobeNewsWire • Sep 30, 2025

The Joint Corp. (JYNT) Q2 2025 Earnings Call Transcript
The Joint Corp. (NASDAQ:JYNT ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Sanjiv Razdan - CEO, President & Director Scott Justin Bowman - Chief Financial Officer Conference Call Participants George Arthur Kelly - ROTH Capital Partners, LLC, Research Division Jeffrey Wallin Van Sinderen - B. Riley Securities, Inc., Research Division Jeremy Scott Hamblin - Craig-Hallum Capital Group LLC, Research Division Nicholas Sherwood - Maxim Group LLC, Research Division David Barnard - Unidentified Company LHA Investor Relations - Unidentified Company Operator Hello, and welcome to the Joint Corp Second Quarter 2025 Financial Results Conference Call.
Seeking Alpha • Aug 9, 2025

The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates
The Joint Corp. (JYNT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year ago.
Zacks Investment Research • Aug 8, 2025

The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
- Expects to reduce 2024 net loss and increase carrying value of assets held for sale by approximately $2.2 million - - Expects to increase first quarter 2025 net income by approximately $0.5 million, resulting in a cumulative increase in carrying value of assets held for sale by approximately $2.7 million - - No change to 2024 or first quarter 2025 Adj. EBITDA -
GlobeNewsWire • Jul 30, 2025

¹ Disclosures

Open an M1 investment account to buy and sell The Joint Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.